IP Library Granted Patent US 8,603,496
Granted Patent B2
US 8,603,496 · App. 12/384,202 · Granted Dec 10, 2013

Compositions and methods for biological remodeling with frozen particle compositions

Inventors: Edward S. Boyden (Cambridge, MA); Daniel B. Cook (Seattle, WA); Roderick A. Hyde (Redmond, WA); Eric C. Leuthardt (St. Louis, MO); Nathan P. Myhrvold (Medina, WA); Elizabeth A. Sweeney (Seattle, WA); Lowell L. Wood, Jr. (Bellevue, WA)
Assignee: The Invention Science Fund I, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,603,496
App. No.
12/384,202
Granted
Dec 10, 2013
Kind
B2
Abstract

Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.

Claims (18)

1. A frozen particle composition, comprising:

one or more frozen hydrogen oxide particles coated in at least one biological remodeling agent including one of collagenase, elastase, collagen, keratin, elastin, fibrin, heparin, fibrinogen, globulin, thrombin, glutaraldehyde-crosslinked pericardium, hyaluronic acid, hydroxylapatite, keratin, ligament, nitinol, polyethylene, polyethylene glycol diacrylate, polyethylene terephthalate fiber, polytetrafluoroethylene, polyglycolic acid, tendon, hyaluronate, chitin, chitosan, polyaldehyde gluronate, Factor XIII, Factor XII, silk, nylon, polyurethane, glycosaminoglycan, poly(α-hydroxyacid), selectin, or glutaraldehyde.

2. The frozen particle composition of claim 1 , further including at least one material that modulates the rate of diffusion or degradation of the at least one biological remodeling agent.

3. The frozen particle composition of claim 1 , wherein the at least one biological remodeling agent includes one or more of a blood cell, chondrocyte, endothelial cell, hepatocyte, keratinocyte, myocyte, osteoblast, osteoclast, osteocyte, mesenchymal cell, stem cell, progenitor cell, or fibroblast.

4. The frozen particle composition of claim 1 , wherein the at least one biological remodeling agent includes one or more of Type I collagen, Type II collagen, Type III collagen, Type VII collagen, Type X collagen, elastin fibers, or soluble elastin.

5. The frozen particle composition of claim 1 , wherein the biological remodeling agent further includes one or more of an angiogenic factor, growth factor, or cytokine.

6. The frozen particle composition of claim 1 , wherein the one or more frozen particles include a plurality of frozen particles that are approximately uniform in size, shape, weight, or density.

7. The frozen particle composition of claim 1 , further including one or more of a reinforcement agent, abrasive, adhesive agent, therapeutic agent, or explosive materials.

8. A frozen particle composition, comprising:

one or more frozen particles including dimethylsulfoxide, cyanoacrylate, polyethylene glycol, and coated in at least one biological remodeling agent including at least one of collagenase, elastase, collagen, keratin, elastin, fibrin, heparin, fibrinogen, globulin, thrombin, glutaraldehyde-crosslinked pericardium, hyaluronic acid, hydroxylapatite, keratin, ligament, nitinol, polyethylene, polyethylene glycol diacrylate, polyethylene terephthalate fiber, polytetrafluoroethylene, polyglycolic acid, tendon, hyaluronate, chitin, chitosan, polyaldehyde gluronate, Factor XIII, Factor XII, silk, nylon, polyurethane, glycosaminoglycan, poly(α-hydroxyacid), selectin, or glutaraldehyde.

9. A frozen particle composition, comprising:

one or more frozen particles including at least one alcohol, and coated in at least one of collagenase, elastase, collagen, keratin, elastin, fibrin, heparin, fibrinogen, globulin, thrombin, glutaraldehyde-crosslinked pericardium, hyaluronic acid, hydroxylapatite, keratin, ligament, nitinol, polyethylene, polyethylene glycol diacrylate, polyethylene terephthalate fiber, polytetrafluoroethylene, polyglycolic acid, tendon, hyaluronate, chitin, chitosan, polyaldehyde gluronate, Factor XIII, Factor XII, silk, nylon, polyurethane, glycosaminoglycan, poly(α-hydroxyacid), selectin, or glutaraldehyde.

10. The frozen particle composition of claim 1 , further including at least one detection material.

11. The frozen particle composition of claim 10 , wherein the detection material includes at least one of a radioactive element, electronic identification device, luminescent substance, fluorescent substance, magnetic particle, or colorimetric material.

12. The frozen particle composition of claim 7 , wherein the at least one reinforcement agent includes at least one of polyaramid, vinylester matrix, metal ceramic, fiberglass, cellulose, broad carbide, aromatic polyamide, nylon, silk, rayon, acetate, modacrylic, olefin, acrylic polymer or copolymer, acrylamide polymer or copolymer, polyester, aromatic polyester, poly-lactic acid, vinyon, saran, spandex, vinalon, aromatic nylon, vinylidene chloride, modal, polybenzimidazole, sulfur, lyocell, orlon, zylon, high-performance polyethylene, polypyridobenzimidazole, vectran, acrylonitrile rubber, diamond, novaculite, borazon, corundum, or zirconia alumina.

13. The frozen particle composition of claim 7 , wherein the at least one therapeutic agent includes at least one of an anti-tumor agent, antimicrobial agent, analgesic, anesthetic, anti-inflammatory agent, vaccine, angiogenic factor, apoptotic promoting factor, cytokine, or anti-coagulant.

14. The frozen particle composition of claim 7 , wherein the at least one explosive material includes nitroglycerine.

15. The frozen particle composition of claim 7 , wherein the at least one adhesive agent includes at least one of an epoxy, urethane, polyurethane, methacrylate, polysulfide, polyanhydride, polydioxanone, poly-p-dioxanone, or zinc polycarboxylate.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016
From: THE INVENTION SCIENCE FUND I LLC
To: GEARBOX, LLC
Reel/Frame 037540/0396 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2013
From: SEARETE LLC
To: THE INVENTION SCIENCE FUND I, LLC
Reel/Frame 031547/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2009
From: BOYDEN, EDWARD S.; COOK, DANIEL B.; HYDE, RODERICK A.; LEUTHARDT, ERIC C.; MYHRVOLD, NATHAN P.; SWEENEY, ELIZABETH A.; WOOD, JR., LOWELL L.
To: SEARETE LLC
Reel/Frame 023197/0468 →
Continuity (30)
Continuation In Part 12384218 · Mar 31, 2009
Continuation In Part 12384216 · Mar 31, 2009
Continuation In Part 12384215 · Mar 31, 2009
Continuation In Part 12384214 · Mar 31, 2009
Continuation In Part 12384212 · Mar 31, 2009
Continuation In Part 12384201 · Mar 31, 2009
Continuation In Part 12383863 · Mar 27, 2009
Continuation In Part 12383851 · Mar 27, 2009
Continuation In Part 12383829 · Mar 27, 2009
Continuation In Part 12383821 · Mar 27, 2009
Continuation In Part 12383265 · Mar 20, 2009
Continuation In Part 12383264 · Mar 20, 2009
Continuation In Part 12383263 · Mar 20, 2009
Continuation In Part 12383260 · Mar 20, 2009
Continuation In Part 12290671 · Oct 31, 2008
Continuation In Part 12290683 · Oct 31, 2008
Continuation In Part 12290685 · Oct 31, 2008
Continuation In Part 12290686 · Oct 31, 2008
Continuation In Part 12290690 · Oct 31, 2008
Continuation In Part 12290691 · Oct 31, 2008
Continuation In Part 12290684 · Oct 31, 2008
Continuation In Part 12290670 · Oct 31, 2008
Continuation In Part 12290664 · Oct 31, 2008
Continuation In Part 12290676 · Oct 31, 2008
Continuation In Part 12290687 · Oct 31, 2008
Continuation In Part 12290677 · Oct 31, 2008
Continuation In Part 12290665 · Oct 31, 2008
Continuation In Part 12290658 · Oct 31, 2008
Continuation In Part 12290659 · Oct 31, 2008
Related Publication 20100112067A1 · May 6, 2010